ICD-10 Code C91.A1 | Mature B-cell leukemia Burkitt-type, in remission Symptoms, Diagnosis, Billing

Mature B-cell leukemia Burkitt-type, in remission is a hematological malignancy characterized by the proliferation of mature B-cells with a specific genetic mutation. This condition is clinically significant as it indicates a phase of treatment response, allowing for accurate documentation and billing. The ICD-10 Code C91.A1 facilitates precise diagnosis, supports healthcare providers in clinical decision-making, and aids in public health reporting.

What is ICD-10 Code C91.A1 for Mature B-cell leukemia Burkitt-type, in remission?

ICD-10 Code C91.A1 represents Mature B-cell leukemia Burkitt-type, in remission, a condition where the aggressive proliferation of B-cells has been controlled through treatment. This code is used when documenting the patient's remission status, ensuring accurate billing and reflecting the patient's clinical condition in healthcare records.

ICD-10 Code C91.A1 – Clinical Definition and Explanation of Mature B-cell leukemia Burkitt-type, in remission

Mature B-cell leukemia Burkitt-type, in remission, is a form of non-Hodgkin lymphoma characterized by rapid cell growth and a specific chromosomal translocation. The condition requires immediate medical attention due to its aggressive nature and potential complications. Remission indicates a favorable response to treatment, necessitating ongoing monitoring.

Key Clinical Features:

• Presence of B-cell markers (CD19, CD20) on flow cytometry.
• Rapidly enlarging lymph nodes or abdominal masses.
• Cytogenetic abnormalities, particularly the MYC gene rearrangement.
• Symptoms of leukemic phase, such as fatigue and fever.

ICD-10 Code C91.A1 for Mature B-cell leukemia Burkitt-type, in remission – SOAP Notes & Clinical Use

ICD-10 Code C91.A1 is utilized in SOAP notes to document the patient's remission status, guiding treatment plans and clinical assessments. It plays a crucial role in both acute and chronic care settings, ensuring comprehensive documentation of the patient's health status and treatment response.

What Does ICD-10 Code C91.A1 for Mature B-cell leukemia Burkitt-type, in remission Mean in SOAP Notes?

In SOAP notes, ICD-10 Code C91.A1 connects subjective patient reports and objective clinical findings to a formal diagnosis of remission. This code is essential for maintaining continuity of care, supporting accurate billing, and meeting EHR documentation standards.

Treatment Options for ICD-10 Code C91.A1 – Mature B-cell leukemia Burkitt-type, in remission

Mature B-cell leukemia Burkitt-type, in remission, requires ongoing management to maintain remission and prevent relapse. Treatment strategies focus on monitoring and supportive care.

Antibiotic Therapy:

• Not applicable as this condition is not infectious.

Supportive Care:

• Regular follow-up appointments for monitoring.
• Management of potential side effects from previous treatments.
• Nutritional support to enhance recovery.

Infection Control:

• Standard precautions to prevent infections due to immunosuppression.
• Education on hygiene practices for patients.

How to Document Symptoms of Mature B-cell leukemia Burkitt-type, in remission (ICD-10 C91.A1) in SOAP Notes

Subjective:

• Patient reports feeling well with no new symptoms.
• Denies fever, night sweats, or weight loss.
• History of previous treatment for Burkitt lymphoma.

Objective:

• Physical examination shows no lymphadenopathy.
• Blood tests indicate normal white blood cell count.
• Bone marrow biopsy shows no evidence of disease.

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more

SOAP Note Guidelines for Diagnosing Mature B-cell leukemia Burkitt-type, in remission (ICD-10 Code C91.A1)

Assessment:

• Diagnosis: Mature B-cell leukemia Burkitt-type, in remission.
• ICD-10 Code: C91.A1.
• No current symptoms or signs of relapse.

Plan:

• Continue regular follow-up every 3 months.
• Monitor for any signs of relapse.
• Educate patient on signs and symptoms to report.

Treatment & Plan Section for ICD-10 Code C91.A1 – Mature B-cell leukemia Burkitt-type, in remission

• Regular monitoring of blood counts and clinical status.
• Supportive care including nutritional counseling.
• Patient education on lifestyle modifications to support health.
• Scheduled follow-up imaging as needed.

Using ICD-10 Code C91.A1 for Mature B-cell leukemia Burkitt-type, in remission in Billing & SOAP Note Compliance

• Ensure accurate documentation of remission status in patient records.
• Use C91.A1 in conjunction with treatment codes for comprehensive billing.
• Document any relevant symptoms or complications to support claims.
• Maintain compliance with coding guidelines to avoid denials.

Related ICD-10 Codes Often Used with Mature B-cell leukemia Burkitt-type, in remission

• C91.00 – Mature B-cell leukemia, not having achieved remission
• C91.01 – Mature B-cell leukemia, in remission
• C83.30 – Non-Hodgkin lymphoma, unspecified
• C83.39 – Other non-Hodgkin lymphoma

ICD-10 Code C91.A1 in Medical Billing and Insurance for Mature B-cell leukemia Burkitt-type, in remission

ICD-10 Code C91.A1 is critical in medical billing, particularly in hospital and outpatient settings, to ensure accurate claims processing.

Billing Notes:

• Document all relevant clinical findings to support the use of C91.A1.
• Use this code in conjunction with treatment and evaluation codes.
• Ensure that the remission status is clearly stated in the medical record.

Common CPT Pairings: